Rate enhancement of the electron transfer of the adrenodoxin-adrenodoxin reductase system by inorganic and nucleotide phosphates  by Yamano, Toshio et al.
Volume 264, number 1, 138-140 FEBS 08406 May 1990 
Rate enhancement of the electron transfer of the adrenodoxin- 
adrenodoxin reductase system by inorganic and nucleotide phosphates 
Toshio Yamanol, Yasuki Nonaka2 and Retsu Miural 
1 Laboratory of Chemistry, Kansai Medical University, 18-19 Uyamahigashi, Hirakata 573 and =Departments of Biochemistry, and 
Molecular and Physiological Chemistry, Osaka University Medical School, 4-3-57 Nakanoshima, Kita-ku. Osaka 530, Japan 
Received 20 February 1990 
Phosphate and pyrophosphate increased the rate of reduction of adrenodoxin by NADPH-adrenodoxin reductase and NADPH, pyrophosphate 
being one order more effective than the former. However, the cytochrome c reduction by the electron transport system was inhibited in the presence 
of inorganic (pyro)phosphate. On the other hand, ADP and ATP enhanced the rates of reduction of both adrenodoxin and cytochrome c through 
adrenodoxin by the electron transport system. GTP also enhanced the rate of reduction of cytochrome c by this system, whereas AMP showed 
no appreciable nhancement. These inorganic and nucleotide phosphates did not affect the rate of ferricyanide reduction by the reductase. 
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1. INTRODUCTION 
The primary structures of adrenodoxin and 
adrenodoxin reductase (NADPH : adrenodoxin ox- 
idoreductase, EC 1.18.1.2) have been well established, 
through chemical analysis of adrenodoxin [l] as well as 
molecular cloning of adrenodoxin [2] and the reductase 
[3,4]. Their three dimensional structures have not yet 
been determined, although a crystallographic study on 
the space group and unit cell dimensions has been car- 
ried out [5]. Through kinetic studies, the firm complex 
formation between adrenodoxin and the reductase has 
become well known [6,7]. However, the mechanism 
underlying the electron transport between adrenodoxin 
and P-450’s remains to be elucidated. We have reported 
that dicarboxylic acids enhance the rate of electron 
transfer from NADPH to cytochrome c via the reduc- 
tase and adrenodoxin [8], noting that the negatively 
charged ligands may affect the capacity of adrenodoxin 
for electron transfer. In this paper, we report that 
(pyro)phosphate ions and nucleotide phosphates 
enhance the rate of reduction of adrenodoxin via the 
reductase. 
2. MATERIALS AND METHODS 
Adrenodoxin reductase was isolated from bovine adrenocortical 
mitochondria and purified to the crystalline state according to the 
procedure of Nonaka et al. [5]. It was kept frozen at -80°C in the 
form of a crystalline suspension, at a concentration of about 
Correspondence address: T. Yamano, Laboratory of Chemistry, 
Kansai Medical University, 18-19 Uyamahigashi, Hirakata 573, 
Japan 
0.3 mM. A small amount of the preparation was taken from the 
stock, diluted 50 times with Tris-HCl buffer and then used for ex- 
periments. The enzyme solution was stable for several days, if stored 
at -20°C. The activity was measured optically as the rate of reduc- 
tion of 0.9 mM ferricyanide at 25°C. The concentration of the reduc- 
tase was estimated from the molecular activity of the reductase, 
10.96/s/FAD of the reductase [9], based on a molar extinction coeffi- 
cient of ferricyanide of 1020 M-i ’ cm-’ at 420 nm [lo]. The concen- 
tration of the reductase was confirmed from its molecular absorbance 
at 450 nm, 10900 M-‘.cm-’ [ll]. Adrenodoxin was crystallized ac- 
cording to the procedure of Ohnishi et al. [12]. The .44i4/Az76 ratio 
was 0.90. The crystalline suspension (about 1.4 mM) was also kept 
frozen at -80°C. It was diluted 25 times as a transient stock solution, 
kept at -20°C and used for experiments after further dilution. The 
concentration of adrenodoxin was determined from the absorbance 
at 414 nm, using the molecular absorbance value of 
11000 M-' . cm-’ [13]. Adrenodoxin exhibits heterogeneity, which 
has been reported to be due to the proteinase attack during prepara- 
tion or storage [14]. Preparations which showed peaks corresponding 
to molecular weights of less than 14000 on SDS polyacrylamide gel 
electrophoresis were not used. Type V cytochrome c from bovine 
heart was purchased from Sigma Co.; its concentration was deter- 
mined using the difference molar extinction coefficient, 
19 mM-i.cm-‘, between enzymatically reduced and oxidized 
cytochrome c [15]. NADPH was obtained from Oriental Yeast Co., 
Ltd, Japan. Other reagents were of analytical grade. Spec- 
trophotometric measurements were carried out with a Shimadzu 
MPS 2000 or Beckman DU 65 spectrophotometer, equipped with a 
thermostated cell holder, using a kinetic program with a digital out- 
put and graphic print-out. A time scan of the electron transport reac- 
tion, from NADPH to cytochrome c via adrenodoxin and the 
reductase, was recorded at 550 nm. 
3. RESULTS AND DISCUSSION 
3.1. Rate enhancement of adrenodoxin reduction by 
adrenodoxin reductase with NADPH in the 
presence of pyrophoshate or phosphate 
The time course of the reduction of adrenodoxin by 
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the reductase was followed as the decrease in the absor- 
bance at 414 nm at much lower concentrations than 
equimolar reductase and at a lower temperature, 
because of the high reaction rates. In the presence of in- 
creasing pyrophosphate concentrations, remarkable 
decreases in absorbance were observed, as shown in 
Fig. 1. Phosphate ions also caused rate enhancement, 
but to a lesser extent than pyrophosphate, as can be 
seen in Fig. 2. 
While the rate enhancement by inorganic 
(pyro)phosphate of adrenodoxin reduction by the 
reductase and NADPH was remarkable, the rate of 
reduction of ferricyanide by the reductase with 
NADPH was similar in Tris-HCI, phosphate and 
pyrophosphate at pH 7.4 (data not shown). 
3.2. Pyrophosphate and phosphate inhibit the 
reduction of cytochrome c via the electron 
transport system from NADPH to adrenodoxin 
Contrary to the enhancement of the rate of reduction 
of adrenodoxin, inorganic phosphate and 
pyrophosphate inhibited the electron transfer from 
adrenodoxin to cytochrome c, depending on the 
(pyro)phosphate concentration. The extent of rate in- 
hibition of cytochrome c reduction was independent of 
the cytochrome c concentration. Lineweaver-Burke 
plots showed that the inhibition by pyrophosphate of 
the electron transfer to cytochrome c was of a non- 
competitive type. Least squares linear plots in the 
absence and presence of pyrophosphate gave a Ki value 
of 9.6 mM. The electron transfer from adrenodoxin to 
cytochrome c was presumably inhibited in such a way 
that the rate constant of the reaction between them was 
decreased, leading to apparent non-competitive inhibi- 
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Fig. 1. Time course of the rate enhancement by pyrophosphate of the 
reduction of adrenodoxin with the reductase and NADPH. Reactions 
were started by the simultaneous addition of adrenodoxin reductase 
and NADPH. The temperature was kept at 20°C. The 
concentrations, in a total volume of 1.0 ml, were: adrenodoxin, 
2.8 PM; adrenodoxin reductase, 6 nM; NADPH, 10 CM; Tris-HCl, 
pH 7.4, 25 mM. The pyrophosphate concentrations were: (0) 
0 mM; (0) 0.25 mM; (+) 0.5 mM; (A) 1.25 mM; (v) 2.5 mM; (m) 
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Fig. 3. Time course of the rate enhancement by ATP of the reduction 
of adrenodoxin with the reductase and NADPH. The reaction 
conditions were the same as in Fig. 1, except hat pyrophosphate was 
replaced by ATP. The ATP concentrations were: (0) OpM; (0) 
5 mM; (*) 10 mM. 5/4M; (A) 10rcM; (7) 50pM; (m) 1OOyM. 
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Fig. 2. Time course of the rate enhancement by phosphate of the 
reduction of adrenodoxin with the reductase and NADPH. The 
reaction conditions were the same as in Fig. 1, except that 
pyrophosphate was replaced by phosphate and the phosphate 
concentrations were: (0) 0 mM; (0) 1.25 mM; (+) 2.5 mM; (A) 
5 mM; (T) 10 mM; (m) 50 mM. 
tion, but the rate limiting step was still the reaction be- 
tween adrenodoxin and the reductase. 
3.3. Rate enhancement of both the reduction of 
adrenodoxin and the reduction of cytochrome c by 
the electron transfer system in the presence of 
nucleotide phosphates 
Rate enhancement of the reduction of adrenodoxin 
by the reductase with NADPH was observed in the 
presence of ATP. As shown in Fig. 3, the effect of 
ATP was less remarkable than that of pyrophosphate, 
but the concentrations used were much lower. The 
enhancement became saturated and leveled off at less 
than 50 ,uM. The rate of cytochrome c reduction was 
measured with low concentrations of adrenodoxin and 
a saturated amount of the reductase, because of the 
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Fig. 4. Percent rate enhancement of the cytochrome c reduction with 
various concentrations of ATP via the electron transfer system from 
NADPH to adrenodoxin. The reaction temperature was 37°C. The 
concentrations, in a total volume of 1.0 ml, were: cytochrome c, 
12 nM; adrenodoxin, 4 nM; adrenodoxin reductase, 60 nM; 
NADPH, 1OpM; Tris-HCl, pH 7.4, 25 mM. 
high rate of reduction of cytochrome c. The percent 
rate enhancement of cytochrome c reduction was defin- 
ed as the ratio of the rate increase in the presence of 
ATP to the rate in its absence. As shown in Fig. 4, the 
concentration dependency was hyperbolic. GTP had a 
similar rate enhancement effect with regard to the ex- 
tent of enhancement and the concentration dependen- 
cy. ADP also gave similar results to those in the case of 
ATP, but AMP was ineffective for the rates of reduc- 
tion of both adrenodoxin and cytochrome c, in contrast 
to ADP and ATP (data not shown). 
Nucleotide phosphates had no appreciable effect on 
the rate of reduction of ferricyanide by the reductase 
with NADPH at the concentrations used in these ex- 
periments. In anaerobic experiments, it was found that 
the rate enhancement of cytochrome c reduction by 
ATP is not due to the electron surplus resulting from 
prevention of the electron flow on autooxidation of 
reduced adrenodoxin. ATP had no effect as to 
stabilization of adrenodoxin against heat treatment 
(data not shown). 
Recently, pyrophosphate was shown to accumulate 
in mitochondria in the presence of Ca2+ ions during 
acetate or butyrate metabolism. The pyrophosphate 
level reached as high as 30 nmol per mg of mitochon- 
drial protein, which is 10 times the basal level 1161. 
Hence, there is a possibility that the rate of electron 
transport is affected by the level of pyrophosphate in 
mitochondria. 
Multiple forms of adrenodoxin have been reported, 
whose carboxyl terminals are different, presumably due 
to proteolytic attack during purification [14]. Vickery 
et al. reported that carboxyl-terminal deleted (des 
116-128)-adrenodoxin i creased the hydroxylation ac- 
tivity with either P-450,,, or P-45Orr,y [17]. Charge in- 
teractions between adrenodoxin and ligands may affect 
the rate of electron transfer at the carboxyl terminal 
domain. 
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